3 Stocks Boosting The Health Care Sector Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 37 points (-0.2%) at 16,809 as of Friday, June 27, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,843 issues advancing vs. 1,114 declining with 177 unchanged.

The Health Care sector currently sits up 0.2% versus the S&P 500, which is down 0.1%. Top gainers within the sector include Taro Pharmaceutical Industries ( TARO), up 13.9%, Intuitive Surgical ( ISRG), up 2.7%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.6%, Endo International ( ENDP), up 1.3% and Valeant Pharmaceuticals International ( VRX), up 1.3%. On the negative front, top decliners within the sector include Alexion Pharmaceuticals ( ALXN), down 1.5%, WellPoint ( WLP), down 0.9%, UnitedHealth Group ( UNH), down 0.7%, Aetna ( AET), down 0.7% and Vertex Pharmaceuticals ( VRTX), down 0.7%.

TheStreet would like to highlight 3 stocks pushing the sector higher today:

3. Community Health Systems ( CYH) is one of the companies pushing the Health Care sector higher today. As of noon trading, Community Health Systems is up $1.29 (2.9%) to $45.44 on average volume. Thus far, 742,009 shares of Community Health Systems exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $43.73-$45.50 after having opened the day at $44.05 as compared to the previous trading day's close of $44.15.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. Community Health Systems has a market cap of $5.3 billion and is part of the health services industry. Shares are up 12.4% year-to-date as of the close of trading on Thursday. Currently there are 12 analysts who rate Community Health Systems a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Community Health Systems as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Community Health Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Edwards Lifesciences ( EW) is up $2.10 (2.5%) to $88.02 on average volume. Thus far, 525,168 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $85.70-$88.11 after having opened the day at $85.76 as compared to the previous trading day's close of $85.91.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $8.9 billion and is part of the health services industry. Shares are up 30.6% year-to-date as of the close of trading on Thursday. Currently there are 10 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Edwards Lifesciences as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Edwards Lifesciences Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Allergan ( AGN) is up $1.43 (0.8%) to $171.98 on light volume. Thus far, 821,410 shares of Allergan exchanged hands as compared to its average daily volume of 4.6 million shares. The stock has ranged in price between $170.05-$172.17 after having opened the day at $170.40 as compared to the previous trading day's close of $170.55.

Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. Allergan has a market cap of $50.3 billion and is part of the drugs industry. Shares are up 53.5% year-to-date as of the close of trading on Thursday. Currently there are 6 analysts who rate Allergan a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates Allergan as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, compelling growth in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Allergan Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices

OPEC Deal Doesn't Boost Production Enough to Drive Down Crude, Gasoline Prices